Incyte
INCY
#1195
Rank
C$26.10 B
Marketcap
C$131.16
Share price
-0.54%
Change (1 day)
28.32%
Change (1 year)

Earnings for Incyte (INCY)

Earnings in 2024: C$0.43 Billion

According to Incyte's latest financial reports the company's current earnings are C$4.81 Billion. In 2024 the company made an earning of C$0.43 Billion a decrease over its 2023 earnings that were of C$1.13 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Incyte from 1994 to 2024

Annual earnings

Year Earnings Change
2024C$0.43 B-62.04%
2023C$1.13 B57.66%
2022C$0.71 B-7.24%
2021C$0.77 B-345.65%
2020-C$0.32 Billion-147.7%
2019C$0.66 B322.02%
2018C$0.15 B-136.94%
2017-C$0.43 Billion-390.76%
2016C$0.14 B1322%
2015C$10.25 M-115.56%
2014-C$65.93 Million-41.4%
2013-C$0.12 Billion87.67%
2012-C$59.96 Million-74.9%
2011-C$0.24 Billion843.59%
2010-C$25.31 Million-88.68%
2009-C$0.23 Billion1.37%
2008-C$0.23 Billion86.16%
2007-C$0.12 Billion17.64%
2006-C$0.11 Billion-28.62%
2005-C$0.15 Billion-36.1%
2004-C$0.23 Billion-2.03%
2003-C$0.23 Billion22.26%
2002-C$0.19 Billion-27.39%
2001-C$0.26 Billion198.72%
2000-C$85.01 Million132.2%
1999-C$36.61 Million-556.86%
1998C$8.01 M-37.23%
1997C$12.76 M-259.32%
1996-C$8.02 Million-45.87%
1995-C$14.81 Million-9.17%
1994-C$16.3 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
C$22.20 B 929.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$16.09 B 646.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$30.56 B 1,316.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$11.19 B 419.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$90.71 M-95.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-C$62.37 Million-102.89%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-C$94.04 Million-104.36%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-C$39.44 Million-101.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-C$75.45 Million-103.50%๐Ÿ‡บ๐Ÿ‡ธ USA